ATXS vs CLOV · rev $706.0K vs rev $1.37B
Astria Therapeutics Inc (ATXS) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
ATXS currently screens at market cap $382.1M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the ATXS and CLOV stock pages for the full models.
Not investment advice.